8:30-8:45 Welcome
8:45-9:45 Keynote Speakers
The Opioid Crisis – National and State Perspectives and Initiatives
This speaker will provide an overview of the crisis on the state and national level, and various efforts occurring in Kansas such as the Kansas Prescription Drug and Opioid Advisory Committee, which developed and is implementing a coordinated, multi-disciplinary statewide strategic plan, to provide a comprehensive approach to the opioid crisis in Kansas.
Adrienne Hearrell, MPH, CPTA
Program Manager, Kansas Department of Health and Environment
Damon West, M.S.
Author, The Coffee Bean: A Simple Lesson to Create Positive Change
9:45-10:00 Break
10:00-11:00 Breakout sessions – 1
An International Comparison of Postoperative Pain Management in Orthopedic Patients
Are opioids effective agents in pain management? In the United States, opioids are considered essential for pain management; however, other nations do not believe so. This talk is focused on comparing pain management protocols in the United States and in Romania, as well as their effectiveness. Our international study has illuminated numerous disparities seen in the United States population, including the questionable efficacy of opioid pain management differences between males and females. With additional studies in the work, one could begin to beg the question if this could be the beginning of the end of the opioid crisis?
Johnathan Dallman
Medical Student, University of Kansas School of Medicine
Harm Reduction and the Prevention of Opioid Overdose Deaths in Kansas
The severity of the opioid epidemic warrants cost-effective, evidence-based strategies that save lives, reduce the strain on our criminal justice and health care systems, and enhance public health. Join us as we discuss key findings from our policy report and learn how we can prevent opioid overdose deaths in Kansas.
Ngoc Vuong
Community Mobilizer, Safe Streets Wichita
Lisa Vayda, RPh, M.S.
Community Advocate, Safe Streets Wichita
Treatment and Recovery Option 1:
HRSA Efforts to Address Substance Use Disorder and Impacts on Maternal Health
During this session, HRSA will share about its efforts to address substance use disorder including its Neonatal Abstinence Syndrome and Psychostimulant Support programs as well as connect participants to substance use related resources and technical assistance.
Rae Hutchinson, Public Health Analyst
Monica Rousseau, Public Health Analyst
Kim Nesbitt, Public Health Analyst
Health Resources and Services Administration, Office of Regional Operations
Treatment and Recovery Option 2:
Medication Assisted Treatment in SW Kansas
This presentation will explain what is medication assisted treatment (MAT), the role of MAT in treatment and recovery, and the limitations of MAT. The presentation will also explore addiction and disease and what contributes to addiction and difficulties patients may face in recovery. This session will also provide an overview of the Genesis Family Health approach to MAT which provides an integrated treatment program between medical and behavioral health.
Samuel Goetschius, APRN
MAT Director, Genesis Family Health
Law Enforcement Option 1:
Building Resilience: A Tactical Guide for Developing a Firm Foundation for Mind, Body and Spirit
Our chosen profession makes us proud because of the purposeful work that we do. But it can also be mentally, emotionally, and physically exhausting. It’s rewarding and tough all at the same time. We came into this profession wanting to change the world but overtime, we watch some of our coworkers and maybe even ourselves end up in unbelievable trauma and adversity. You will gain numerous tools and concepts to strengthen and grow your resilience, how to use those tools when in trauma, and the idea that you can actually grow through adversity. These tools and ideas will help you build your resilience and strengthen your mind, body and spirit.
Brenda Dietzman
Wayfinder Consulting, LLC
Law Enforcement Option 2:
Novel Benzos: The Next U.S. Drug Epidemic
Benzodiazepines have quietly joined the ranks of America’s most lethal drugs, with misuse of both Xanax and counterfeit street pills increasingly common. These fake “novel benzos” are much stronger than traditional benzodiazepines, containing new chemicals specifically designed for illicit markets, to evade loopholes in Chinese drug law.
Ben Westhoff
Journalist, Grove Atlantic
11:00-11:15 Break
11:15 – 12:15 Breakout sessions – 2
Characterizing patient encounters of opioid use disorders in the Midwest
The presentation will characterize patient encounters of opioid use disorders (OUDs) in the Midwest (including Kansas and Missouri) and compare selected patient encounter characteristics between two census divisions. In addition, the presentation will describe secondary databases related to OUDs and available at University of Missouri – Kansas City.
Yifei Liu
Associate Professor, University of Missouri – Kansas City School of Pharmacy
Suman Sahil
Principal Database Programmer and Analyst,University of Missouri – Kansas City School of Medicine
Stacy Farr
Director of Outcomes Research, Saint Luke’s Health System
Holly Hagle
Assistant Research Professor, University of Missouri – Kansas City’s School of Nursing and Health Studies
Harm Reduction: Establishing, Implementing, and Innovating
Harm Reduction. What does it look like in rural Kansas? How does it work and to whwat extent? What can make it even more effective moving forward? Join us as we discuss these topics and more.
Seth Dewey
Health Educator/Trainer, Reno County Health Department
Ana Woodburn, AAS, KCPM, PCCM
President, Kansas Recovery Network
Jacci Espinosa, CPCM
Accounts Manager, Kansas Recovery Network
Treatment & Recovery Option 1:
Why the Hate for Naltrexone?
Methadone remains more widely-used than naltrexone in medication-assisted treatment for opioids. While both have benefits and drawbacks, naltrexone receives scant media coverage and has fallen out of favor among harm reduction advocates. Why? This session discusses why naltrexone is a much-neglected, but much-needed, tool in the opioid crisis.
Ben Westhoff
Journalist, Grove Atlantic
Treatment & Recovery Option 2:
More Than Dependency: The Neurobiology of Addiction
Despite clinical advances in the treatment of Opioid and Stimulant Use Disorders, those battling addiction continue to face poor treatment outcomes. In recent years we have seen increased efforts for multidisciplinary treatment with an emphasis on Medication Assisted Treatment (MAT) for Opioid and Alcohol Use Disorders. Current MAT practice recommendations do not provide an intervention for stimulant use disorder. Literature does not provide a well-defined evidenced based pharmacotherapeutic intervention for Stimulant Use Disorder. Traditional interventions for Stimulant Use Disorder focus on contingency management, psychosocial Intervention, and psychotherapy with limited efficacy.
Sobriety is more than abstinence. The neurobiological framework of mental illness and addiction is integrated; thus, treatment must be integrated to include medical, psychosocial, psychological, and psychiatric interventions.
This presentation will focus on educating the audience regarding the neurobiology of addiction, specific effects from stimulant and opioid use, points of consideration for treatment and relapse prevention.
Eric Thomason
Director of Behavioral Health and Addiction Treatment Services, Community Health Center of South East Kansas
From Police to Prevention: We Can Prevent Overdose Deaths
Shattering the unspoken biases around Naloxone availability and administration to empower and equip medical professionals, pharmacists and law enforcement/first responders to prevent opioid overdose deaths. Challenging perspectives on overdose emergency response and practices to save lives and provide second chances for recovery.
Daniel Donovan
Community Support Specialist, DCCCA
12:15 – 1:00 Lunch Break
1:00 – 2:00 Breakout Session 3
Hospital Initiated Opioid Overdose Programming: Engaging Patients In Care Coordination (EPICC)
This presentation will discuss Missouri’s hospital-based bridge model, Engaging Patients in Care Coordination (EPICC), whereby opioid overdose survivors are immediately linked to treatment and ancillary support services, e.g. housing. Since 2016, EPICC has been launched in St. Louis, Columbia, Kansas City, Springfield, and Branson – over 13,000 opioid overdose survivors have been served to date
Shawn Billings
Vice President of Substance Use Programming, Missouri Hospital Association
Prevention Option 1:
Drug Endangered Children and Creating Community Alliances
Participants will be introduced to the concept of Drug Endangered Children. The course identifies factors which create an environment where substance use endangers the health and safety of children. It will discuss best practices for working with families of drug endangered children and methods for inter-agency cooperation to provide safe environments for children.
Jennifer Gassman
Parent Child Assistance Program Supervisor, Kansas Children’s Service League
Mike Parsons
Prevention Program Coordinator, DCCCA
Prevention Option 2:
Substance Use Prevention & Adverse Childhood Experiences (ACEs): Protection and Risk Factors
Preventing early adversity before it begins by promoting safe, stable, nurturing relationships and environments is crucial in order to achieve multiple health, well-being, and productivity goals across generations. To assure the conditions that prevent many early adversities from occurring in the first place, comprehensive approaches that minimize risk factors and promote protective factors at all levels of the social ecology are critically important. Participants in this session will receive an introduction to Adverse Childhood Experiences (ACE) science, with a focus on the impact ACEs can have on substance use. In addition, the session will focus on evidence-based prevention strategies for ACEs.
Dr. Christopher Jones
CAPT, US Public Health Service Acting Director, National Center for Injury Prevention and Control; Centers for Disease Control and Prevention
Overdose Investigation Tips
This session will cover some of the common issues that arise in overdose prosecutions and how to create standards and procedures to ensure overdose investigations result in prosecutable cases.
Skipper Jacobs
Assistant United States Attorney,Department of Justice, District of Kansas
2:00 – 2:15 Break
2:15 -3:15 Breakout Session 4
Implementing Opioid and Substance Use Screenings for Perinatal Patients
This session will discuss best practices in screening for opioid and substance use disorders in perinatal populations in various care settings. We will review KDHE’s perinatal intervention recommendations and briefly cover the impact of early intervention of behavioral health disorders on long-term maternal and fetal health.
Patricia Carrillo
Program Manager, Kansas Connecting Communities
Prevention Option 1:
Real Time Data and Immediate Response in Substance Use Trends
We discuss the need for real time overdose data but also the challenges that come along with it. Including partnerships, privacy, stigma and others. Most importantly we discuss where we hope to go not just in Reno County but in the state of Kansas.
Seth Dewey
Health Educator/Trainer, Reno County Health Department
DJ Gering
Public Health Anaylst, Reno County Health Department
Prevention Option 2:
Identifying Prescription Drug Prevention Needs & Resources with K-TRACS
Put data into action by using information from the Kansas prescription drug monitoring program to create community prevention priorities. Understand prescribing trends and naloxone availability in your community, then learn how to engage prescribers and pharmacies to help prevent prescription drug misuse, abuse and diversion.
Gayle Donaldson
Public Information Officer, K-TRACS / Kansas Board of Pharmacy
Treatment & Recovery Option 1:
Supports and Services to Turbocharge The Recovery Journey
This session will identify at least two best practices in engaging with and supporting individuals experiencing behavioral health challenges, discuss the importance of a trauma-informed, person-centered approach when engaging and serving people with behavioral health concerns, describe at least two wraparound services and why they are important in supporting an individual’s recovery journey, and explain the impact of stigma upon individuals with behavioral health challenges and implications for treatment access and overall success.
Steven Samra, MPA
Senior Associate, C4 Innovations
Treatment & Recovery Option 2:
Compassion and Continuity of Care during the COVID Pandemic
Compassion and continuity of care has become a central point in addiction treatment since the COVID-19 pandemic began. This presentation will show how addiction professionals shifted to become essential health care providers while remaining flexible and creative. Staff self-care will be emphasized because of the impact on them by COVID-19.
Stacy Chamberlain
Program Director, BHG Overland Park
They’re Real and They Kill – Drugs in Kansas
Assistant Special Agent in Charge Rogeana Patterson-King, lead of DEA operations in Kansas, will talk about the changing world of drug trafficking – from the rising popularity of counterfeit pills to new ways people are finding drugs. She’ll also delve into the role of law enforcement in preventing these deadly poisons from reaching Kansas neighborhoods, and where education and prevention is critical to putting the brakes on the overdose death crisis.
Rogeana Patterson
Assistant Special Agent in Charge, DEA
3:15-3:30 Break
3:30 – 4:30 Closing Keynote Session
Update on Psychostimulant Use Disorder in the United States
Blake Fagan, MD
Family Physician, Mountain Area Health Education Center (MAHEC)